The genetic heterogeneity of uterine leiomyomata

Obstetrics and Gynecology Clinics of North America
Melissa K LobelCynthia C Morton

Abstract

Research investigating the genetics of UL has already been successful in gathering epidemiologic evidence for heritability, establishing the clonal and mosaic nature of these tumors, correlating genotypic and phenotypic characteristics, defining cytogenetic subgroups, and identifying specific genes involved in tumorigenesis. Although UL are known to be benign tumors, the impact they have on the lives of so many women can only be described as "malignant". For this reason, continuing the quest to ascertain the genes, functions, and mechanisms integral to UL development is absolutely imperative. Genetic tests for personalized medical management of women with fibroids is at the threshold for providing the most appropriate treatments (Fig. 3), and combined with developing less invasive therapies portends a brighter future for a major health problem for women.

References

Jul 1, 1992·American Journal of Obstetrics and Gynecology·S A TreloarA C Heath
Jul 15, 1992·Cancer Genetics and Cytogenetics·Y Y OzisikA A Sandberg
Oct 1, 1991·Human Pathology·J Hu, U Surti
May 10, 1991·International Journal of Cancer. Journal International Du Cancer·C Sreekantaiah, A A Sandberg
May 1, 1991·Genes, Chromosomes & Cancer·G CalabreseG Palka
Aug 1, 1991·Cancer Genetics and Cytogenetics·N PandisF Mitelman
Feb 1, 1991·Cancer Genetics and Cytogenetics·P Dal CinI Brosens
Mar 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·R ReevesM S Nissen
Apr 1, 1991·British Journal of Obstetrics and Gynaecology·G B CandianiL Villa
May 1, 1991·Cancer Genetics and Cytogenetics·M Kiechle-SchwarzA A Sandberg
Jun 1, 1991·Cancer Genetics and Cytogenetics·A M MeloniA A Sandberg
Jun 1, 1991·Cancer Genetics and Cytogenetics·R VanniG Faa
Sep 1, 1990·Genes, Chromosomes & Cancer·R VanniH Van Den Berghe
Apr 1, 1990·British Journal of Obstetrics and Gynaecology·B J VollenhovenD L Healy
Oct 1, 1990·American Journal of Clinical Pathology·S F Cramer, A Patel
Nov 1, 1990·Genes, Chromosomes & Cancer·N PandisF Mitelman
May 1, 1990·Genes, Chromosomes & Cancer·M Nibert, S Heim
Jan 1, 1990·Cancer Genetics and Cytogenetics·J MarkB Wedell
Mar 1, 1990·Cancer Genetics and Cytogenetics·M NilbertF Mitelman
Jul 15, 1990·Cancer Genetics and Cytogenetics·S X FanA A Sandberg
Feb 1, 1989·British Journal of Obstetrics and Gynaecology·W H MattaM Nye
Jan 1, 1989·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·G HavelJ Mark
Oct 1, 1989·Journal of Comparative Pathology·K J FieldC M Lang
Jun 1, 1989·Fertility and Sterility·E M Coutinho, M T Gonçalves
May 1, 1989·American Journal of Obstetrics and Gynecology·J P RiceB S Mahony
Feb 1, 1989·Cancer Genetics and Cytogenetics·S N SaitA A Sandberg
Jan 1, 1989·Cancer Genetics and Cytogenetics·R VanniU Lecca
Sep 1, 1988·Cancer Genetics and Cytogenetics·L BoghosianA A Sandberg
May 1, 1988·Cancer Genetics and Cytogenetics·C Turc-CarelA A Sandberg
Feb 15, 1986·Cancer Genetics and Cytogenetics·S HeimH Willén
Aug 15, 1970·American Journal of Obstetrics and Gynecology·D E TownsendG McClelland
Oct 1, 1981·Fertility and Sterility·V C Buttram, R C Reiter
Sep 1, 1980·American Journal of Obstetrics and Gynecology·D MuramJ H Walters
Jan 1, 1995·Cytogenetics and Cell Genetics·L C TsuiK H Grzeschik

❮ Previous
Next ❯

Citations

Oct 28, 2008·Seminars in Reproductive Medicine·Xiaoping Luo, Nasser Chegini
Dec 3, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shyamal D PeddadaDonna Day Baird
Jul 12, 2014·Journal of Cell Communication and Signaling·Caitlin Fujisawa, John J Castellot
Dec 25, 2012·Fertility and Sterility·Michael DroschNicole Schmidt
Sep 2, 2010·Cancer Genetics and Cytogenetics·Dominique Nadine MarkowskiJörn Bullerdiek
Oct 29, 2013·Obstetrics and Gynecology International·Andrea CiavattiniPasquapina Ciarmela
Jan 30, 2008·American Journal of Obstetrics and Gynecology·Karen L HuyckCynthia C Morton
Nov 4, 2015·Archives of Gynecology and Obstetrics·Hans-Joachim AhrendtDolores Foth
Mar 21, 2017·Journal of the American Academy of Dermatology·Viral M PatelW Clark Lambert
Dec 17, 2008·Women's Health·Jerome H Check
Mar 23, 2011·Reproductive Sciences·Hilary RoederPhyllis C Leppert
Oct 21, 2015·Current Opinion in Obstetrics & Gynecology·Salvatore G VitaleFerdinando A Gulino
Sep 26, 2007·Human Molecular Genetics·Jennelle C Hodge, Cynthia C Morton
May 14, 2010·Systems Biology in Reproductive Medicine·Yong JiangJean Y J Wang
May 18, 2021·Molecular and Cellular Biochemistry·Malak El SabehMostafa A Borahay
Sep 2, 2021·Menopause : the Journal of the North American Menopause Society·Minghong ShenSha Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Chromosomes

Artificial chromosomes are genetically engineered chromosomes derived from the DNA of a species. Discover the latest research on artificial chromosomes here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis